309 related articles for article (PubMed ID: 8841740)
1. Cidofovir.
Lea AP; Bryson HM
Drugs; 1996 Aug; 52(2):225-230; discussion 231. PubMed ID: 8841740
[TBL] [Abstract][Full Text] [Related]
2. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
Plosker GL; Noble S
Drugs; 1999 Aug; 58(2):325-45. PubMed ID: 10473024
[TBL] [Abstract][Full Text] [Related]
3. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
Lalezari JP; Stagg RJ; Kuppermann BD; Holland GN; Kramer F; Ives DV; Youle M; Robinson MR; Drew WL; Jaffe HS
Ann Intern Med; 1997 Feb; 126(4):257-63. PubMed ID: 9036797
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis.
Lalezari JP; Kuppermann BD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S27-31. PubMed ID: 9058615
[TBL] [Abstract][Full Text] [Related]
5. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.
Lalezari JP; Holland GN; Kramer F; McKinley GF; Kemper CA; Ives DV; Nelson R; Hardy WD; Kuppermann BD; Northfelt DW; Youle M; Johnson M; Lewis RA; Weinberg DV; Simon GL; Wolitz RA; Ruby AE; Stagg RJ; Jaffe HS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):339-44. PubMed ID: 9525435
[TBL] [Abstract][Full Text] [Related]
6. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Ann Intern Med; 1997 Feb; 126(4):264-74. PubMed ID: 9036798
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644
[TBL] [Abstract][Full Text] [Related]
8. Cidofovir in the treatment of cytomegaloviral disease.
Kendle JB; Fan-Havard P
Ann Pharmacother; 1998 Nov; 32(11):1181-92. PubMed ID: 9825085
[TBL] [Abstract][Full Text] [Related]
9. Nursing considerations in the use of cidofovir for CMV retinitis in patients with AIDS: report of a roundtable meeting.
Martin MA; Kane C
J Assoc Nurses AIDS Care; 1997; 8(5):66-74. PubMed ID: 9298471
[TBL] [Abstract][Full Text] [Related]
10. Lack of reactivation of cytomegalovirus retinitis in an AIDS patient, during and after stopping long-term cidofovir treatment: case report.
Papastamopoulos V; Botsis C; Paparizos VA; Kyriakis KP; Zagoraios Y; Stavrianeas NG
J Chemother; 2000 Jun; 12(3):258-60. PubMed ID: 10877523
[TBL] [Abstract][Full Text] [Related]
11. Cidofovir (HPMPC) potent against CMV.
Posit Aware; 1995; ():5. PubMed ID: 11362567
[TBL] [Abstract][Full Text] [Related]
12. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance.
Smith IL; Taskintuna I; Rahhal FM; Powell HC; Ai E; Mueller AJ; Spector SA; Freeman WR
Arch Ophthalmol; 1998 Feb; 116(2):178-85. PubMed ID: 9488269
[TBL] [Abstract][Full Text] [Related]
13. Cidofovir: a new therapy for cytomegalovirus retinitis.
Lalezari JP
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S22-6. PubMed ID: 9058614
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
Wolf DL; RodrÃguez CA; Mucci M; Ingrosso A; Duncan BA; Nickens DJ
J Clin Pharmacol; 2003 Jan; 43(1):43-51. PubMed ID: 12520627
[TBL] [Abstract][Full Text] [Related]
15. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
Cherrington JM; Fuller MD; Lamy PD; Miner R; Lalezari JP; Nuessle S; Drew WL
J Infect Dis; 1998 Dec; 178(6):1821-5. PubMed ID: 9815243
[TBL] [Abstract][Full Text] [Related]
16. Cidofovir in the treatment of cytomegalovirus (CMV) retinitis.
Garcia CR; Torriani FJ; Freeman WR
Ocul Immunol Inflamm; 1998 Sep; 6(3):195-203. PubMed ID: 9785611
[No Abstract] [Full Text] [Related]
17. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis.
Rahhal FM; Arevalo JF; Munguia D; Taskintuna I; Chavez de la Paz E; Azen SP; Freeman WR
Ophthalmology; 1996 Jul; 103(7):1078-83. PubMed ID: 8684797
[TBL] [Abstract][Full Text] [Related]
18. Cidofovir approved.
PI Perspect; 1996 Sep; (No 19):14-5. PubMed ID: 11363898
[TBL] [Abstract][Full Text] [Related]
19. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.
Jabs DA; Enger C; Forman M; Dunn JP
Antimicrob Agents Chemother; 1998 Sep; 42(9):2240-4. PubMed ID: 9736542
[TBL] [Abstract][Full Text] [Related]
20. Cidofovir. Review of current and potential clinical uses.
Safrin S; Cherrington J; Jaffe HS
Adv Exp Med Biol; 1999; 458():111-20. PubMed ID: 10549383
[No Abstract] [Full Text] [Related]
[Next] [New Search]
